Anti-Obesity Drugs Market valued at USD 5.9 Bn in 2024, growing at 16.5% CAGR to reach USD 20.02 Bn by 2032. Driven by GLP-1 therapies and rising obesity rates.
Anti-Obesity Drugs Market Overview
Maximize Market Research is a Business Consultancy Firm that has published a detailed analysis of the “ Anti-Obesity Drugs Market ”. The report...